Area of research
Oncology · Molecular Biology
Research interest
Research interests include Gut microbiota and health, Cancer Immunotherapy and Biomarkers, Clostridium difficile and Clostridium perfringens research, and Pancreatic and Hepatic Oncology Research.
Impact of the ONCOBIOME network in cancer microbiome research
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Melanoma and microbiota: Current understanding and future directions
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors